Söndag 27 April | 03:36:18 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-03-31 08:50 Bokslutskommuniké 2025
2025-08-31 08:50 Kvartalsrapport 2025-Q2
2025-07-01 N/A X-dag ordinarie utdelning OODA 0.00 SEK
2025-06-30 N/A Årsstämma
2025-03-31 - Bokslutskommuniké 2024
2024-08-30 - Kvartalsrapport 2024-Q2
2024-06-03 - X-dag ordinarie utdelning OODA 0.00 SEK
2024-05-31 - Årsstämma
2024-03-31 - Bokslutskommuniké 2023
2023-11-29 - Extra Bolagsstämma 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-08-16 - Split OODA 40:1
2023-05-09 - X-dag ordinarie utdelning OODA 0.00 SEK
2023-03-21 - Bokslutskommuniké 2022
2023-02-21 - Extra Bolagsstämma 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-08-23 - Kvartalsrapport 2022-Q2
2022-05-24 - Kvartalsrapport 2022-Q1
2022-05-09 - X-dag ordinarie utdelning OODA 0.00 SEK
2022-02-24 - Bokslutskommuniké 2021
2021-12-17 - Extra Bolagsstämma 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-06-11 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-05-06 - X-dag ordinarie utdelning OODA 0.00 SEK
2021-02-11 - Bokslutskommuniké 2020
2020-11-16 - Kvartalsrapport 2020-Q3
2020-10-03 - Extra Bolagsstämma 2020
2020-08-17 - Kvartalsrapport 2020-Q2
2020-06-18 - X-dag ordinarie utdelning OODA 0.00 SEK
2020-06-17 - Årsstämma

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorInformationsteknik
IndustriProgramvara
oodash är en bolagsgrupp med fokus på företag inom mjukvara-som-tjänst (SaaS) och artificiell intelligens (AI) framförallt inom beslutsstöd (BI) och datasäkerhet (GDPR). Bolagsgruppen tillhandahåller även AI-tjänster i form av konsultation, utbildning och implementering. Bolagsgruppen verkar på en global marknad. Huvudkontoren är belägna i Stockholm och München.
2022-08-08 08:00:00

EPTI AB (publ) portfolio company Apotekamo today announces a completed financing round of SEK 26.5 million on a pre-money valuation of SEK 152 million. Subscribers are both existing and new shareholders, including Angelgate AG and the former Bosnian professional footballer and current sporting director of the Bundesliga club FC Bayern Munich, Hasan “Brazzo” Salihamidžić. Salihamidžić becomes Apotekamo's third largest owner and will support the company in various marketing activities. EPTI invests a total of SEK 5 million, whose holding in Apotekamo amounts to 42 percent of the votes and capital after the completion of the financing round.

“We are pleased to continue to support Apotekamo in its growth journey. The company is a typical EPTI case where we are involved in launching, developing and upscaling a niche player on a digitally immature market. Apotekamo has made great operational progress over the past year and has seen strong growth in both returning customers and orders. We are happy and proud to have Hasan Salihamidžić on board, an internationally recognized football personality that will contribute to increased visibility”, says Arli Mujkic, CEO and founder of EPTI

Apotekamo is a leading online pharmacy focusing on Southeast Europe. In addition to a comprehensive range of both over-the-counter and prescription drugs, the company provides digital services regarding order processing and payment solutions for external suppliers on Aptekamo’s platform.

In the new financing round of SEK 26.5 million, the Bosnian football icon Hasan “Brazzo” Salihamidžić becomes Apotekamo’s third largest owner. Salihamidžić has a long career in international professional football and has represented clubs such as FC Bayern Munich and Juventus FC. He is currently the sports director of his previous club FC Bayern Munich.

“I am very impressed by Apotekamo's fast growth and its management. The company has a proven concept in other markets, so it is only a matter of time before the same applies to the rest of Europe. I see a great opportunity in strengthening the healthcare market in my home region and look very much forward to support the company in various marketing activities”, says Hasan Salihamidžić

Apotekamo was first launched in Serbia, and expanded to Bosnia and Herzegovina during the first quarter of 2022, following the acquisition of a local pharmacy. The newly raised capital is intended for further geographical expansion, marketing activities, and development of the company's logistics solution during 2022.

“We are delighted with the trust from existing and new investors, especially given the current market climate and the geopolitical situation. It feels great that we find common ground on our vision to do good for the society and at the same time become the leading online pharmacy in Southeast Europe. During the first half-year period of 2022, Apotekamo increased its order intake by 740 percent compared with the corresponding period last year. Finally, we are of course happy to welcome Hasan Salihamidžić as new major shareholder in the company", says Srdjan Milic, CEO, Apotekamo

For further information, please contact:
Arli Mujkic, CEO, EPTI AB
E-mail: arli@epti.com
Phone: +49 176 626 999 64

Adam Bäckström, CFO, EPTI AB
E-mail: adam@epti.com
Phone: +46 73 026 68 26

About EPTI
EPTI invests capital and operational support for companies, entrepreneurs and founders to build market-leading innovative companies under the motto “We Empower Innovation”. As a venture builder, this is done by adding experience from other founders, capital, resources, processes, state-of-the-art technology as well as commercial execution and marketing. EPTI also starts companies and joint ventures with driven co-founders and companies. The companies in EPTI’s portfolio are in the segments Gaming, Fintech, Marketplace, SaaS and Core. Since the start in 2017, a portfolio of more than 25 companies has been built up, of which the majority-owned companies comprise a total of approximately 200 coworkers in eight countries around Europe. EPTI is more than an investment company, it is partly an investment company and partly a service company. A venture builder for founders, by founders.

For more information, see EPTI’s website www.epti.com

The Company’s Certified Adviser is Eminova Fondkommission AB | +46 (0)8-684 211 00 | info@eminova.se